Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Dow
McKinsey
Moodys
AstraZeneca

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Salvinorin A


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Salvinorin A?

Salvinorin A is an investigational drug.

There have been 4 clinical trials for Salvinorin A. The most recent clinical trial was a Phase 1 trial, which was initiated on December 14th 2017.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Johns Hopkins University, Yale University, and National Alliance for Research on Schizophrenia and Depression.

There are ninety-two US patents protecting this investigational drug and three hundred and ninety-eight international patents.

Recent Clinical Trials for Salvinorin A
TitleSponsorPhase
Effects of Salvinorin A on Brain FunctionJohns Hopkins UniversityPhase 1/Phase 2
Placebo Controlled Study of Sublingual Salvinorin ACalifornia Pacific Medical Center Research InstituteN/A
Effects of Salvinorin A in Healthy ControlsNational Alliance for Research on Schizophrenia and DepressionPhase 1

See all Salvinorin A clinical trials

Clinical Trial Summary for Salvinorin A

Top disease conditions for Salvinorin A
Top clinical trial sponsors for Salvinorin A

See all Salvinorin A clinical trials

US Patents for Salvinorin A

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Salvinorin A   Start Trial Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof   Start Trial
Salvinorin A   Start Trial Pharmaceutical composition and method of manufacturing CURE PHARMACEUTICAL HOLDING CORP. (Oxnard, CA)   Start Trial
Salvinorin A   Start Trial Pharmaceutical compositions resistant to abuse EGALET LTD. (London, GB)   Start Trial
Salvinorin A   Start Trial Multifunctional aminoquinoline therapeutic agents LOHOCLA RESEARCH CORPORATION (Evanston, IL)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Salvinorin A

Drugname Country Document Number Estimated Expiration Related US Patent
Salvinorin A European Patent Office 3324975 2035-07-22   Start Trial
Salvinorin A World Intellectual Property Organization (WIPO) 2017015309 2035-07-22   Start Trial
Salvinorin A Australia 2010211376 2029-02-06   Start Trial
Salvinorin A Australia 2013257533 2029-02-06   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
McKesson
Dow
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.